Molecular imaging using prostate-specific membrane antigen [6] (PSMA) ligand positron-emission tomography (PET) has transformed PCa imaging, outperforming conventional imaging modalities [7, 8], particularly in detecting local relapses and metastasis at low PSA levels [9]. Here, FOLH1 is linked to posterior cortical atrophy.